A review of coverage of our peer-reviewed research, in the mainstream and healthcare press.
Two articles in the new issue of The American Journal of Managed Care are gaining notice in the healthcare press this week. David Salazar of DrugStore News was among those who wrote about “The Impact of Formulary Drug Exclusion Policies on Patients and Heatlhcare Costs,” which is a review 26 studies. The article, by researchers at the Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies, in the Center for the Evaluation of Value and Risk in Health, found that while there are exceptions, most research shows that exclusions save money without harming patients.
The article, “Opinions on the Hospital Readmission Reduction Program: Results of a National Survey of Hospital Leaders,” drew plenty of reader and press interest. Jacqueline Belliveau of RevenueCycle Intelligence covered the results of the survey, which found that two-thirds of respondents feel CMS’ financial penalties for not meeting 30-day readmission targets are having a major effect on their efforts to decrease readmissions. The authors, from Harvard’s T.H. Chan School of Public Health, also found that three-quarter of the leaders faulted CMS for failing to account for differences in the socioeconomic mix of hospital populations.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More